Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors

AIM OF THE STUDY: The majority of patients with chronic myeloid leukaemia (CML) respond to tyrosine kinase inhibitors (TKI), while allogeneic haematopoietic cell transplantation (HCT) is indicated in selected clinical situations. HCT carries the risk of severe complications, while the toxicity profi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Contemp Oncol (Pozn)
Autores principales: Piekarska, Agnieszka, Gil, Lidia, Jakitowicz, Karolina, Prejzner, Witold, Komarnicki, Mieczysław, Hellmann, Andrzej
Formato: Artigo
Lenguaje:Inglês
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5371710/
https://ncbi.nlm.nih.gov/pubmed/28373825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2016.64607
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares